Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation

S. A. Giralt, K. F. Mangan, R. T. Maziarz, J. S. Bubalo, R. Beveridge, D. D. Hurd, F. L. Mendoza, E. B. Rubenstein, T. J. DeGroot, M. W. Schuster

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences